Cite

HARVARD Citation

    Righi, E. et al. (2022). Dalbavancin in the treatment of acute bacterial skin and skin structure and other infections: a safety evaluation. Expert opinion on drug safety. 21 (9), pp. 1171-1181. [Online]. 
  
Back to record